(2010). Drug Administration FDA (2010) Possible fracture risk with high dose, long-term use of proton pump inhibitors. http://www. fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationfor PatientsandProviders/ucm213206.htm.
(2009). Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates.
(2006). Long-term proton pump inhibitor therapy and risk of hip fracture.
(2008). Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.
(2006). Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database.